In rare cases of overdose excessive loss of water and electrolytes should be treated by encouraging the patient to drink plenty of fluid.
3 years
Docusol solution should not be taken
-
- in the presence of abdominal pain, intestinal obstruction, nausea or if vomiting occurs.
None known
Sorbitol 70% Glycerol Povidone
Methyl p-hydroxybenzoate
Propyl p-hydroxybenzoate
Sodium dihydrogen phosphate dehydrate
Disodium hydrogen phosphate dodecahydrate
Sodium benzoate
Citric acid anhydrous
Aspartame
Strawberry flavour
Propylene glycol
Purified water
Oral solution
Liquid syrupy, clear, nearly colourless and with homogeneous appearance.
Stimulant laxatives increase intestinal motility and often cause abdominal cramp.
There have been spontaneous reports of burning sensation in mouth and throat following the use of Docusol. Patients are advised to drink plenty of water or flavoured drink after taking the solution.
Reporting of suspected adverse reactions
Reporting suspected adverse reaction after authorisation of the medicinal product is important. It allows continued monitoring of the benefit / risk balance of the medicinal product. Healthcare professionals are asked to report any suspected adverse reactions via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard.
None stated
a) To prevent and treat chronic constipation
b) As an adjunct in abdominal radiological procedures
ATC code: A06AA02 Laxatives, softeners, emollients
Docusate sodium acts as a faecal softener by increasing the penetration of water and fats.
Docusate sodium exerts its effects by means of its physical surfactant properties. However there is some evidence that it is absorbed from the gastrointestinal tract and excreted in bile.
03/05/2016
Docusol Adult Solution
Docusate Sodium Adult 50mg/5ml Oral Solution
Typharm Ltd. Unit
14D Wendover Road
Rackheath Industrial Estate
Norwich
NR13 6LH
None
Glass bottle with a plastic screw cap with a transparent seal.Each bottle contains 125ml or 300ml.
PL 00551/0006
There is inadequate evidence of safety of the drug in human pregnancy, nor is there evidence from animal work that it is free from hazard, but it has been in wide use for many years without apparent ill consequence. Use in pregnancy only if the benefits outweigh the potential risks. Docusate sodium is excreted in breast milk and should therefore be used with caution in lactating mothers.
5ml of the solution contains docusate sodium 50mg
Excipient(s) with known effect:
Aspartame (E951) 15mg per dose of syrup (5 mL)
Sorbitol 70% (E420) 1209 mg per dose of syrup (5 mL)
Glycerol (E422) 628.5 mg per dose of syrup (5 mL)
Methyl p-hydroxybenzoate (E218) 5 mg per dose of syrup (5 mL)
Propyl p-hydroxybenzoate (E216) 2.5 mg per dose of syrup (5 mL)
Propylene glycol (E1520) 0.003 mL per dose of syrup (5 mL)
Docusol should not be given to infants under six months. Prolonged use can precipitate the onset of an atonic non-functioning colon and hypokalaemia.
Docusol Adult Solution contains sorbitol. Patients with rare hereditary problems of fructose intolerance should not take this medicine.
Docusol Adult Solution contains glycerol. May cause headache, stomach upset and diarrhoea.
Docusol Adult Solution contains methyl p-hydroxybenzoate and propyl p-hydroxybenzoate. May cause allergic reactions (possibly delayed).
Docusol Adult Solution contains aspartame which is a source of phenylalanine. May be harmful for people with phenylketonuria.
Docusol Adult Solution contains propylene glycol which may cause alcohol-like symptoms.
None known
Adults: 10ml to 15ml three times a day. Take as a single dose followed by plenty of water or flavoured drink e.g. milk or orange juice. Maximum daily dose 50ml.
Treatment should be commenced with large doses which should be decreased as the condition of the patient improves.
For barium meals: 40ml to be taken with the meal.
Elderly: There is no evidence to suggest that an adjustment of the dosage is necessary in the elderly.
Children: For administration to children and infants over 6 months use Docusol Paediatric Solution 0.25% w/v.
For barium meals: 40ml to be taken with the meal.
None
09/03/1998 / 13/07/2006
Docusol solution should not be taken concurrently with mineral oil. Anthraquinone derivatives should be taken in reduced doses, if administered with Docusol as their absorption is increased.
